CFO Bets $722K Against the Tape
Summit's CFO just dropped $722,250 at $14.45 while the stock shows selling pressure across every timeframe. That's contrarian conviction from the money guy who sees the books daily. The technicals are ugly with 80% sell signals and RSI at 36, but insiders on this biotech have been right about 2 out of 3 times in recent months. Risk is real here with support thin at $14.17, but when a CFO backs up the truck this size against momentum, he's seeing something the market isn't pricing in yet.
The Filing
| Ticker | SMMT |
| Company | Summit Therapeutics Inc. |
| Insider | Manmeet Singh Soni, COO and CFO |
| Buy amount | $722,250 |
| Filing date | June 4, 2026 |
| Conviction | Favorable · 68/100 |
| Setup type | Oversold Bounce |
Ultimate members received this analysis in real time.